Hikma Pharmaceuticals USA Inc
[3] Clean Beauty Standards Institute
Every patient responds differently to peptide therapy
According to recent statistical data among all COVID-19 patients, ~19% of them were severe or critical, most of which displayed remarkably increased serum levels of pro-inflammatory cytokines and subsets of immune cells ( The Immune Response and CRS in COVID-19 Recent advances in the pathophysiologic understanding of COVID-19 suggests that CRS has a great association with the severity of disease due to increased serum levels of tumor necrosis factor (TNF-), granulocyte-colony stimulating factor (G-CSF), interferon gamma-induced protein 10 (IP-10), monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein 1 (MIP1A) ( Initial reports have also determined that a multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 may cause public concern
LISTEN TO THE PODCAST Also available on Spotify and Apple Podcasts In this episode of the Thyroid Pharmacist Healing Conversations podcast , I interview Lexi Yoo, a double board-certified nurse practitioner and founder of Yoo Direct Health, who brings an innovative lens to treating Hashimotos, autoimmunity, and hormonal dysfunction
Medications are prescribed by a licensed practitioner and dispensed by a licensed pharmacy
